Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Ann Surg Oncol. 2013 Jul 12;20(12):10.1245/s10434-013-3096-1. doi: 10.1245/s10434-013-3096-1

TABLE 2.

Pairwise comparison of mutant GNAS samples by grade of dysplasia, epithelial differentiation, and duct involvement

Dysplasia grade n Mutant, n (%)
Low-grade dysplasia 20 10 (50)
Intermediate-grade dysplasia 19 12 (63)
P 0.523
Intermediate-grade dysplasia 19 12 (63)
High-grade dysplasia 47 30 (64)
P >0.99
Low-grade dysplasia 20 10 (50)
High-grade dysplasia 47 30 (64)
P 0.415
Gastric 53 27 (51)
Pancreatobiliary 7 5 (71)
P 0.432
Intestinal 12 12 (100)
Pancreatobiliary 7 5 (71)
P 0.123
Oncocytic 2 0 (0)
Pancreatobiliary 7 5 (71)
P 0.167
Intestinal 12 12 (100)
Gastric 53 27 (51)
P 0.001
Oncocytic 2 0 (0)
Gastric 53 27 (51)
P 0.491
Oncocytic 2 0 (0)
Intestinal 12 12 (100)
P 0.011
Mixed duct 9 5 (56)
Main duct 30 18 (60)
P >0.99
Branch duct 37 21 (57)
Main duct 30 18 (60)
P 0.809
Branch duct 37 21 (57)
Mixed duct 9 5 (56)
P >0.99

P values are for testing whether the proportion of mutated samples is different between patient groups